VitaNova Life Sciences Corp
VNOVUS売上高
$3M
百万USD
営業利益
$1M
百万USD
純利益
$1M
百万USD
ROE
44.6%
最新FY
EPS
$0.03
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $-0M | - |
| FY2021 | Q2 | - | $0M | - |
| FY2021 | Q3 | - | $-0M | - |
| FY2021 | FY | - | $-0M | - |
| FY2022 | Q1 | - | $0M | $0.00 |
| FY2022 | Q3 | - | $0M | - |
| FY2022 | FY | - | $0M | $0.02 |
| FY2023 | Q2 | - | $0M | $0.00 |
| FY2023 | Q3 | - | $-0M | $0.00 |
| FY2023 | FY | - | $-0M | $0.00 |
| FY2024 | Q1 | - | $-0M | $0.00 |
| FY2024 | Q2 | - | $-0M | $0.00 |
| FY2024 | Q3 | - | $0M | $0.00 |
| FY2024 | FY | $1M | $0M | $0.01 |
| FY2025 | Q1 | $0M | $-0M | $0.00 |
| FY2025 | Q2 | $0M | $0M | $0.00 |
| FY2025 | Q3 | $0M | $0M | $0.00 |
| FY2025 | FY | $3M | $1M | $0.03 |
| FY2026 | Q1 | $0M | $-0M | $0.00 |
| FY2026 | Q2 | $0M | $0M | $0.00 |
| FY2026 | Q3 | $1M | $-0M | $-0.01 |
財務データ
| 指標 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | - | $1M | $3M |
| 営業利益 | - | $-0M | $-0M | $-0M | $-0M | $-0M | $0M | $1M |
| 純利益 | $-0M | $-0M | $-0M | $-0M | $0M | $-0M | $0M | $1M |
| 総資産 | $0M | $0M | $0M | $0M | $0M | $0M | $1M | $2M |
| 純資産 | - | - | - | - | - | - | - | - |
| 自己資本 | $0M | $-0M | $-0M | $-0M | $-0M | $-0M | $1M | $2M |
| 営業CF | $-0M | $-0M | $-0M | $-0M | $0M | $-0M | $-0M | $0M |
| EPS | - | - | - | - | $0.02 | $0.00 | $0.01 | $0.03 |
| BPS | $0.01 | $-0.01 | $-0.02 | $-0.03 | $-0.01 | $-0.01 | $0.04 | $0.08 |
| ROE | -3.8% | 211.3% | 59.0% | 29.8% | -399.2% | 40.9% | 13.3% | 44.6% |